Heterogeneous nuclear ribonucleoprotein K supports vesicular stomatitis virus replication by regulating cell survival and cellular gene expression

Journal of Virology

Volumn 87, Issue 18, 2013, Pages 10059-10069

  Dinh, Phat X ^a   Das, Anshuman ^a   Franco, Rodrigo ^a   Pattnaik, Asit K ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; PLASMID DNA; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RESTRICTED INTRACELLULAR ANTIGEN 1A; T LYMPHOCYTE RESTRICTED INTRACELLULAR ANTIGEN 1B; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN FUNCTION; SEQUENCE HOMOLOGY; VESICULAR STOMATITIS VIRUS; VIROGENESIS; VIRUS ASSEMBLY; VIRUS ENTRY; VIRUS REPLICATION;

ANIMALS; APOPTOSIS; CELL LINE; CELL SURVIVAL; GENE EXPRESSION REGULATION; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN K; HOST-PATHOGEN INTERACTIONS; HUMANS; TRANSCRIPTION, GENETIC; VESICULOVIRUS; VIRUS REPLICATION;

EID: 84883297707     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01257-13     Document Type: Article

References (65)

1. Choi HS, Hwang CK, Song KY, Law PY, Wei LN, Loh HH. 2009. Poly(C)-binding proteins as transcriptional regulators of gene expression. Biochem. Biophys. Res. Commun. 380:431-436.
2. Ostareck-Lederer A, Ostareck DH. 2012. Precision mechanics with multifunctional tools: how hnRNP K and hnRNPs E1/E2 contribute to posttranscriptional control of gene expression in hematopoiesis. Curr. Protein Pept. Sci. 13:391-400.
3. Bomsztyk K, Denisenko O, Ostrowski J. 2004. hnRNP K: one protein multiple processes. Bioessays 26:629-638.
4. Ostareck-Lederer A, Ostareck DH, Rucknagel KP, Schierhorn A, Moritz B, Huttelmaier S, Flach N, Handoko L, Wahle E. 2006. Asymmetric arginine dimethylation of heterogeneous nuclear ribonucleoprotein K by protein-arginine methyltransferase 1 inhibits its interaction with c-Src. J. Biol. Chem. 281:11115-11125.
5. Habelhah H, Shah K, Huang L, Ostareck-Lederer A, Burlingame AL, Shokat KM, Hentze MW, Ronai Z. 2001. ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation. Nat. Cell Biol. 3:325-330.
6. Naarmann IS, Harnisch C, Flach N, Kremmer E, Kuhn H, Ostareck DH, Ostareck-Lederer A. 2008. mRNA silencing in human erythroid cell maturation: heterogeneous nuclear ribonucleoprotein K controls the expression of its regulator c-Src. J. Biol. Chem. 283:18461-18472.
7. Wang N, Zhang P, Guo X, Zhou Z, Sha J. 2011. Hnrnpk, a protein differentially expressed in immature rat ovarian development, is required for normal primordial follicle assembly and development. Endocrinology 152:1024-1035.
8. Laursen LS, Chan CW, ffrench-Constant C. 2011. Translation of myelin basic protein mRNA in oligodendrocytes is regulated by integrin activation and hnRNP-K. J. Cell Biol. 192:797-811.
9. Chen LC, Chung IC, Hsueh C, Tsang NM, Chi LM, Liang Y, Chen CC, Wang LJ, Chang YS. 2010. The antiapoptotic protein, FLIP, is regulated by heterogeneous nuclear ribonucleoprotein K and correlates with poor overall survival of nasopharyngeal carcinoma patients. Cell Death Diff. 17:1463-1473.
10. Tang FM, Li WM, Chen Y, Wang DM, Han J. 2008. Expression of hnRNP K in lung adenocarcinoma cells. Sichuan Da Xue Xue Bao Yi Xue Ban 39:823-826.
11. Wu CS, Chang KP, Chen LC, Chen CC, Liang Y, Hseuh C, Chang YS. 2012. Heterogeneous ribonucleoprotein K and thymidine phosphorylase are independent prognostic and therapeutic markers for oral squamous cell carcinoma. Oral Oncol. 48:516-522.
12. Xiao Z, Ko HL, Goh EH, Wang B, Ren EC. 2013. hnRNP K suppresses apoptosis independent of p53 status by maintaining high levels of endogenous caspase inhibitors. Carcinogenesis [Epub ahead of print.] doi:10 .1093/carcin/bgt085.
13. van Domselaar R, Quadir R, van der Made AM, Broekhuizen R, Bovenschen N. 2012. All human granzymes target hnRNP K that is essential for tumor cell viability. J. Biol. Chem. 287:22854-22864.
14. White M, Xia G, Gao R, Wakamiya M, Sarkar PS, McFarland K, Ashizawa T. 2012. Transgenic mice with SCA10 pentanucleotide repeats show motor phenotype and susceptibility to seizure: a toxic RNA gain-offunction model. J. Neurosci. Res. 90:706-714.
15. Gao FH, Wu YL, Zhao M, Liu CX, Wang LS, Chen GQ. 2009. Protein kinase C-delta mediates down-regulation of heterogeneous nuclear ribonucleoprotein K protein: involvement in apoptosis induction. Exp. Cell Res. 315:3250-3258.
16. Lin JY, Li ML, Huang PN, Chien KY, Horng JT, Shih SR. 2008. Heterogeneous nuclear ribonuclear protein K interacts with the enterovirus 71 5= untranslated region and participates in virus replication. J. Gen. Virol. 89:2540-2549.
17. Shih SR, Stollar V, Li ML. 2011. Host factors in enterovirus 71 replication. J. Virol. 85:9658-9666.
18. Zhang W, Zhang X, Tian C, Wang T, Sarkis PT, Fang Y, Zheng S, Yu XF, Xu R. 2008. Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression. Cell Microbiol. 10:112-121.
19. Ng LF, Chan M, Chan SH, Cheng PC, Leung EH, Chen WN, Ren EC. 2005. Host heterogeneous ribonucleoprotein K (hnRNP K) as a potential target to suppress hepatitis B virus replication. PLoS Med. 2:e163. doi:10 .1371/journal.pmed.0020163.
20. Schmidt T, Striebinger H, Haas J, Bailer SM. 2010. The heterogeneous nuclear ribonucleoprotein K is important for herpes simplex virus-1 propagation. FEBS Lett. 584:4361-4365.
21. Kanlaya R, Pattanakitsakul SN, Sinchaikul S, Chen ST, Thongboonkerd V. 2010. Vimentin interacts with heterogeneous nuclear ribonucleoproteins and dengue nonstructural protein 1 and is important for viral replication and release. Mol. Biosyst. 6:795-806.
22. Marchand V, Santerre M, Aigueperse C, Fouillen L, Saliou JM, Van Dorsselaer A, Sanglier-Cianferani S, Branlant C, Motorin Y. 2011. Identification of protein partners of the human immunodeficiency virus 1 tat/rev exon 3 leads to the discovery of a new HIV-1 splicing regulator, protein hnRNP K. RNA Biol. 8:325-342.
23. Bourai M, Lucas-Hourani M, Gad HH, Drosten C, Jacob Y, Tafforeau L, Cassonnet P, Jones LM, Judith D, Couderc T, Lecuit M, Andre P, Kummerer BM, Lotteau V, Despres P, Tangy F, Vidalain PO. 2012. Mapping of chikungunya virus interactions with host proteins identified nsP2 as a highly connected viral component. J. Virol. 86:3121-3134.
24. Burnham AJ, Gong L, Hardy RW. 2007. Heterogeneous nuclear ribonuclear protein K interacts with Sindbis virus nonstructural proteins and viral subgenomic mRNA. Virology 367:212-221.
25. Hsieh TY, Matsumoto M, Chou HC, Schneider R, Hwang SB, Lee AS, Lai MM. 1998. Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein K. J. Biol. Chem. 273:17651-17659.
26. Hernaez B, Escribano JM, Alonso C. 2008. African swine fever virus protein p30 interaction with heterogeneous nuclear ribonucleoprotein K (hnRNP-K) during infection. FEBS Lett. 582:3275-3280.
27. Gross H, Hennard C, Masouris I, Cassel C, Barth S, Stober-Grasser U, Mamiani A, Moritz B, Ostareck D, Ostareck-Lederer A, Neuenkirchen N, Fischer U, Deng W, Leonhardt H, Noessner E, Kremmer E, Grasser FA. 2012. Binding of the heterogeneous ribonucleoprotein K (hnRNP K) to the Epstein-Barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expression. PLoS One 7:e42106. doi:10.1371/journal.pone .0042106.
28. van Domselaar R, de Poot SA, Remmerswaal EB, Lai KW, ten Berge IJ, Bovenschen N. 2013. Granzyme M targets host cell hnRNP K that is essential for human cytomegalovirus replication. Cell Death Differ. 20: 419-429.
29. Dinh PX, Beura LK, Panda D, Das A, Pattnaik AK. 2011. Antagonistic effects of cellular poly(C) binding proteins on vesicular stomatitis virus gene expression. J. Virol. 85:9459-9471.
30. Dinh PX, Beura LK, Das PB, Panda D, Das A, Pattnaik AK. 2013. Induction of stress granule-like structures in vesicular stomatitis virusinfected cells. J. Virol. 87:372-383.
31. Mikula M, Dzwonek A, Karczmarski J, Rubel T, Dadlez M, Wyrwicz LS, Bomsztyk K, Ostrowski J. 2006. Landscape of the hnRNP K proteinprotein interactome. Proteomics 6:2395-2406.
32. Pettit Kneller EL, Connor JH, Lyles DS. 2009. hnRNPs Relocalize to the cytoplasm following infection with vesicular stomatitis virus. J. Virol. 83: 770-780.
33. Panda D, Das A, Dinh PX, Subramaniam S, Nayak D, Barrows NJ, Pearson JL, Thompson J, Kelly DL, Ladunga I, Pattnaik AK. 2011. RNAi screening reveals requirement for host cell secretory pathway in infection by diverse families of negative-strand RNA viruses. Proc. Natl. Acad. Sci. U. S. A. 108:19036-19041.
34. Piecyk M, Wax S, Beck AR, Kedersha N, Gupta M, Maritim B, Chen S, Gueydan C, Kruys V, Streuli M, Anderson P. 2000. TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. EMBO J. 19:4154-4163.
35. Das SC, Nayak D, Zhou Y, Pattnaik AK. 2006. Visualization of intracellular transport of vesicular stomatitis virus nucleocapsids in living cells. J. Virol. 80:6368-6377.
36. Das SC, Pattnaik AK. 2004. Phosphorylation of vesicular stomatitis virus phosphoprotein P is indispensable for virus growth. J. Virol. 78:6420-6430.
37. Beura LK, Sarkar SN, Kwon B, Subramaniam S, Jones C, Pattnaik AK, Osorio FA. 2010. Porcine reproductive and respiratory syndrome virus nonstructural protein 1β modulates host innate immune response by antagonizing IRF3 activation. J. Virol. 84:1574-1584.
38. Agbottah ET, Traviss C, McArdle J, Karki S, St Laurent GC, 3rd, Kumar A. 2007. Nuclear Factor 90(NF90) targeted to TAR RNA inhibits transcriptional activation of HIV-1. Retrovirology 4:41. doi:10.1186/1742-4690-4-41.
39. Shabman RS, Leung DW, Johnson J, Glennon N, Gulcicek EE, Stone KL, Leung L, Hensley L, Amarasinghe GK, Basler CF. 2011. DRBP76 associates with Ebola virus VP35 and suppresses viral polymerase function. J. Infect. Dis. 204(Suppl 3):S911-S918.
40. Wang P, Song W, Mok BW, Zhao P, Qin K, Lai A, Smith GJ, Zhang J, Lin T, Guan Y, Chen H. 2009. Nuclear factor 90 negatively regulates influenza virus replication by interacting with viral nucleoprotein. J. Virol. 83:7850-7861.
41. White MC, Gao R, Xu W, Mandal SM, Lim JG, Hazra TK, Wakamiya M, Edwards SF, Raskin S, Teive HA, Zoghbi HY, Sarkar PS, Ashizawa T. 2010. Inactivation of hnRNP K by expanded intronic AUUCU repeat induces apoptosis via translocation of PKC to mitochondria in spinocerebellar ataxia 10. PLoS Genet. 6:e1000984. doi:10.1371/journal.pgen .1000984.
42. Revil T, Pelletier J, Toutant J, Cloutier A, Chabot B. 2009. Heterogeneous nuclear ribonucleoprotein K represses the production of proapoptotic Bcl-xS splice isoform. J. Biol. Chem. 284:21458-21467.
43. Tian Q, Streuli M, Saito H, Schlossman SF, Anderson P. 1991. A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell 67:629-639.
44. Tian Q, Taupin J, Elledge S, Robertson M, Anderson P. 1995. Fasactivated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis. J. Exp. Med. 182:865-874.
45. Samuel S, Tumilasci VF, Oliere S, Nguyen TL, Shamy A, Bell J, Hiscott J. 2010. VSV oncolysis in combination with the BCL-2 inhibitor obatoclax overcomes apoptosis resistance in chronic lymphocytic leukemia. Mol. Ther. 18:2094-2103.
46. Lallemand C, Blanchard B, Palmieri M, Lebon P, May E, Tovey MG. 2007. Single-stranded RNA viruses inactivate the transcriptional activityof p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB. Oncogene 26:328-338.
47. Pearce AF, Lyles DS. 2009. Vesicular stomatitis virus induces apoptosis primarily through Bak rather than Bax by inactivating Mcl-1 and Bcl-XL. J. Virol. 83:9102-9112.
48. Cureton DK, Burdeinick-Kerr R, Whelan SP. 2012. Genetic inactivation of COPI coatomer separately inhibits vesicular stomatitis virus entry and gene expression. J. Virol. 86:655-666.
49. Subramaniam VN, Peter F, Philp R, Wong SH, Hong W. 1996. GS28, a 28-kilodalton Golgi SNARE that participates in ER-Golgi transport. Science 272:1161-1163.
50. Lee HO, Byun YJ, Cho KO, Kim SY, Lee SB, Kim HS, Kwon OJ, Jeong SW. 2011. GS28 protects neuronal cell death induced by hydrogen peroxide under glutathione-depleted condition. Korean J. Physiol. Pharmacol. 15:149-156.
51. Sun NK, Huang SL, Chien KY, Chao CC. 2012. Golgi-SNARE GS28 potentiates cisplatin-induced apoptosis by forming GS28-MDM2-p53 complexes and by preventing the ubiquitination and degradation of p53. Biochem. J. 444:303-314.
52. Haley B, Paunesku T, Protic M, Woloschak GE. 2009. Response of heterogeneous ribonuclear proteins (hnRNP) to ionising radiation and their involvement in DNA damage repair. Int. J. Rad. Biol. 85:643-655.
53. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M, Attardi LD, Regev A, Lander ES, Jacks T, Rinn JL. 2010. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142:409-419.
54. Huang TG, Ebert O, Shinozaki K, Garcia-Sastre A, Woo SL. 2003. Oncolysis of hepatic metastasis of colorectal cancer by recombinant vesicular stomatitis virus in immune-competent mice. Mol. Ther. 8:434-440.
55. Ebert O, Shinozaki K, Huang TG, Savontaus MJ, Garcia-Sastre A, Woo SL. 2003. Oncolytic vesicular stomatitis virus for treatment of orthotopic hepatocellular carcinoma in immune-competent rats. Cancer Res. 63: 3605-3611.
56. Chang G, Xu S, Watanabe M, Jayakar HR, Whitt MA, Gingrich JR. 2010. Enhanced oncolytic activity of vesicular stomatitis virus encoding SV5-F protein against prostate cancer. J. Urol. 183:1611-1618.
57. Wollmann G, Rogulin V, Simon I, Rose JK, van den Pol AN. 2010. Some attenuated variants of vesicular stomatitis virus show enhanced oncolytic activity against human glioblastoma cells relative to normal brain cells. J. Virol. 84:1563-1573.
58. Critchley-Thorne RJ, Simons DL, Yan N, Miyahira AK, Dirbas FM, Johnson DL, Swetter SM, Carlson RW, Fisher GA, Koong A, Holmes S, Lee PP. 2009. Impaired interferon signaling is a common immune defect in human cancer. Proc. Natl. Acad. Sci. U. S. A. 106:9010-9015.
59. Chen LC, Liu HP, Li HP, Hsueh C, Yu JS, Liang CL, Chang YS. 2009. Thymidine phosphorylasemRNAstability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNP K in nasopharyngeal carcinoma cells. Oncogene 28:1904-1915.
60. Benelli R, Monteghirfo S, Balbi C, Barboro P, Ferrari N. 2009. Novel antivascular efficacy of metronomic docetaxel therapy in prostate cancer: hnRNP K as a player. Int. J. Cancer 124:2989-2996.
61. Izquierdo JM, Valcarcel J. 2007. Two isoforms of the T-cell intracellular antigen 1 (TIA-1) splicing factor display distinct splicing regulation activities. Control of TIA-1 isoform ratio by TIA-1-related protein. J. Biol. Chem. 282:19410-19417.
62. Li W, Li Y, Kedersha N, Anderson P, Emara M, Swiderek KM, Moreno GT, Brinton MA. 2002. Cell proteins TIA-1 and TIAR interact with the 3= stem-loop of the West Nile virus complementary minus-strand RNA and facilitate virus replication. J. Virol. 76:11989-12000.
63. Bomben R, Dal-Bo M, Benedetti D, Capello D, Forconi F, Marconi D, Bertoni F, Maffei R, Laurenti L, Rossi D, Del Principe MI, Luciano F, Sozzi E, Cattarossi I, Zucchetto A, Rossi FM, Bulian P, Zucca E, Nicoloso MS, Degan M, Marasca R, Efremov DG, Del Poeta G, Gaidano G, Gattei V. 2010. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features. Clin. Cancer Res. 16:620-628.
64. Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M, Taccioli C, Zanesi N, Garzon R, Aqeilan RI, Alder H, Volinia S, Rassenti L, Liu X, Liu CG, Kipps TJ, Negrini M, Croce CM. 2008. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc. Natl. Acad. Sci. U. S. A. 105:5166-5171.
65. Ostareck DH, Ostareck-Lederer A, Wilm M, Thiele BJ, Mann M, Hentze MW. 1997. mRNA silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 3= end. Cell 89:597-606.